Citadel Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-495,358
Closed -$161M 15779
2024
Q1
$161M Sell
495,358
-395,062
-44% -$97M 0.03% 457
2023
Q4
$170M Buy
890,420
+522,447
+142% +$98.7M 0.03% 419
2023
Q3
$73.3M Buy
367,973
+321,500
+692% +$76M 0.02% 807
2023
Q2
$13.3M Sell
46,473
-115,306
-71% -$32M ﹤0.01% 2332
2023
Q1
$35.1M Sell
161,779
-21,993
-12% -$4.29M 0.01% 1393
2022
Q4
$37.8M Buy
183,772
+80,540
+78% +$20.4M 0.01% 1348
2022
Q3
$28.7M Buy
+103,232
New +$26.3M 0.01% 1520
2022
Q2
Sell
-48,505
Closed -$8.56M 14427
2022
Q1
$10.1M Sell
48,505
-37,289
-43% -$6.15M ﹤0.01% 2952
2021
Q4
$15.3M Buy
85,794
+49,723
+138% +$9.81M ﹤0.01% 2385
2021
Q3
$7.43M Sell
36,071
-50,608
-58% -$9.94M ﹤0.01% 3589
2021
Q2
$16.4M Sell
86,679
-27,264
-24% -$4.46M ﹤0.01% 2335
2021
Q1
$14.8M Buy
113,943
+35,836
+46% +$4.3M ﹤0.01% 2380
2020
Q4
$8.1M Sell
78,107
-77,451
-50% -$6.71M ﹤0.01% 2916
2020
Q3
$11.8M Sell
155,558
-336,192
-68% -$19.1M ﹤0.01% 2094
2020
Q2
$23.3M Sell
491,750
-184,582
-27% -$7.6M 0.01% 1385
2020
Q1
$22.4M Buy
676,332
+392,183
+138% +$15.6M 0.01% 1142
2019
Q4
$12.5M Buy
284,149
+112,878
+66% +$4.17M 0.01% 1971
2019
Q3
$5.13M Buy
171,271
+145,771
+572% +$6.19M ﹤0.01% 3078
2019
Q2
$1.46M Sell
25,500
-232,117
-90% -$11.3M ﹤0.01% 5075
2019
Q1
$8.62M Buy
+257,617
New +$8.56M ﹤0.01% 2253

Other funds holding SWAV

Citadel Advisors's SWAV Position: Q2 2024 in Review

Citadel Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 495,358 shares — an estimated $161M sold.

Citadel Advisors first reported a position in SWAV in Q1 2019 and held it in 20 quarters. The position peaked at $170M in Q4 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Citadel Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 495,358 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $161M.
  • Citadel Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
  • Citadel Advisors's Shockwave Medical, Inc. Common Stock position peaked at $170M in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.